Cyber-biosecurity threats are escalating as malicious actors target critical infrastructure, biotech firms, and research institutions. This briefer provides an overview of the trends and critical risks at the nexus of cybersecurity and biosecurity. It then offers high-level recommendations for addressing these risks.
As new strategies enter implementation stages, CSR is kicking off a writing series to publicly highlight the progress we are monitoring. This is the first in an ongoing series that will highlight the status of key Nolan Center recommendations we made in the past.
This briefer provides an overview of proposed biodefense spending in the U.S. government’s FY24 budget across all relevant federal agencies, including the Department of Defense, Health and Human Services, Homeland Security, and others. The Nolan Center’s analysis is designed to highlight notable changes in funding, potentially important new programs, and areas for improvement in vital…
On June 7, CSR hosted an event with former Executive Office of the President policymakers on the importance of reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA).
Habitat fragmentation, ecosystem degradation, land conversion, deforestation, and wildlife trade have all contributed to the steady increase in disease spillover over the past several decades.
NSABB’s recommendations cover research involving enhanced pandemic potential pathogens, as well as dual-use research of concern.
Nolan Center experts examine the Biden Administration’s new National Biodefense Strategy and Implementation Plan and its accompanying National Security Memorandum.
By Jackson du Pont On Tuesday, September 27th, the Council on Strategic Risks partnered with Building Stronger Futures to host a Congressional Luncheon with Congressman Ritchie Torres [D-NY] and Dr. Beth Cameron. Rep. Torres introduced Dr. Cameron, who currently serves as a Professor at the Brown University School of Public Health and Senior Advisor to…
ASPR’s new elevated role would make it the lead agency for internal hiring, as well as deploying and working with the industrial base via purchasing contracts to prepare for strong responses to future infectious disease outbreaks.
By: Dr. Ryan Duncombe Last week, a puzzling new monkeypox outbreak appeared in the United States after new cases popped up in the United Kingdom, Portugal, Spain, and Canada. As of May 20, there are now a total of over 70 confirmed cases in multiple countries. Public health officials are working hard to understand how…